Immune activation, steroid resistancy and bipolar disorder

Bipolar Disorders

Volumn 4, Issue SUPPL. 1, 2002, Pages 73-74

  Kupka, R W ^a   Breunis, M N ^b   Knijff, E ^b   Ruwhof, C ^b   Nolen, W A ^a   Drexhage, H A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LITHIUM; STEROID; THYROID ANTIBODY;

AFFECTIVE NEUROSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HASHIMOTO DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; IMMUNE SYSTEM; IMMUNOMODULATION; MANIC DEPRESSIVE PSYCHOSIS; MONOCYTE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE ACTIVATION;

ADRENAL CORTEX HORMONES; BIPOLAR DISORDER; CYTOKINES; HUMANS; MONOCYTES; PITUITARY-ADRENAL SYSTEM; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; THYROIDITIS, AUTOIMMUNE;

EID: 0036382426     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.4.s1.29.x     Document Type: Article

References (7)

1. Kupka RW, Hillegers MHJ, Nolen WA, Breunis N, Drexhage HA. Immunological aspects of bipolar disorder. Acta Neuropsychiatr 2000; 12: 86-90.
2. Rybakowski JK. The effect of lithium on the immune system. Human Psychopharmacol Clin Exp 1999; 14: 345-353.
3. Post RM, Nolen WA, Kupka RW et al. The Stanley Foundation Bipolar Network. 1. Rationale and methods. Br J Psychiatry 2001; 178 (Suppl. 41): s169-s176.
4. Kupka RW, Nolen WA, Altshuler LL et al. The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 2001; 178 (Suppl. 41): s177-s183.
5. Kupka RW, Nolen WA, Post RM et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry 2002; 51: 305-311.
6. Breunis MN, Kupka RW, Nolen WA et al. High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder. Biological Psychiatry in press.
7. McQuade R, Young AH. Future therapeutic targets in mood disorders: the glucocorticoid receptor. Br J Psychiatry 2000; 177: 390-395.